This Education Series provides a practical overview of CHE, with emphasis on recognition in primary
care, assessment of disease burden and impact on function, aetiological classification, and key
differential diagnoses. It also outlines evidence‑based management principles, indications for
specialist referral, and the role of newer treatment options, such as delgocitinib cream, for patients
with moderate-to-severe, inadequately controlled CHE.
Independent expert commentary provided by Associate Professor Monisha Gupta, Director of
dermatology at SWSLHD, based at Liverpool.
Please login below to download this issue (PDF)